U.S. markets open in 5 hours 24 minutes
  • S&P Futures

    3,815.25
    -23.75 (-0.62%)
     
  • Dow Futures

    31,427.00
    -38.00 (-0.12%)
     
  • Nasdaq Futures

    12,462.50
    -201.25 (-1.59%)
     
  • Russell 2000 Futures

    2,176.00
    -13.70 (-0.63%)
     
  • Crude Oil

    66.66
    +0.57 (+0.86%)
     
  • Gold

    1,691.70
    -6.80 (-0.40%)
     
  • Silver

    25.41
    +0.12 (+0.47%)
     
  • EUR/USD

    1.1879
    -0.0045 (-0.38%)
     
  • 10-Yr Bond

    1.5540
    0.0000 (0.00%)
     
  • Vix

    27.58
    -0.99 (-3.47%)
     
  • GBP/USD

    1.3814
    -0.0014 (-0.10%)
     
  • USD/JPY

    108.4860
    +0.1040 (+0.10%)
     
  • BTC-USD

    50,032.03
    -186.44 (-0.37%)
     
  • CMC Crypto 200

    1,010.72
    +67.54 (+7.16%)
     
  • FTSE 100

    6,659.02
    +28.50 (+0.43%)
     
  • Nikkei 225

    28,743.25
    -121.07 (-0.42%)
     

Elekta wins lawsuit against Livian GmbH

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

STOCKHOLM, March 8, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that the London Court of International Arbitration (LCIA) has awarded in favor of Elekta in a dispute with Livian GmbH (formerly humediQ GmbH).

The arbitration, reported in the latest interim report (Q3 2020/21), is now finally settled whereby all claims against Elekta group companies are rejected in full.

For further information, please contact:
Mattias Thorsson, VP Corporate Communications
Tel: +46 70 865 8012, e-mail: Mattias.Thorsson@elekta.com
Time zone: CET: Central European Time

Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25, e-mail: cecilia.ketels@elekta.com
Time zone: CET: Central European Time

About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/elekta/r/elekta-wins-lawsuit-against-livian-gmbh,c3301556

The following files are available for download:

Cision
Cision

View original content:http://www.prnewswire.com/news-releases/elekta-wins-lawsuit-against-livian-gmbh-301242178.html

SOURCE Elekta